Cryoablation is a novel treatment currently used to treat benign breast tumors (called fibroadenomas). Cryoablation is now being studied in patients with certain types of small breast cancer. The treatment places a small probe in the center of the cancer and subsequently uses liquid nitrogen to destroy breast cancer tumors by freezing them.

In the treatment of fibroadenomas, cryoablation has proven less invasive and less likely to affect cosmetic appearance than surgery. It could be possible for breast cancer patients to enjoy the same benefits in the future.

Cryoablation for Benign Breast Tumor Treatment

Fibroadenomas are benign breast tumors. They most frequently occur in women during their reproductive years. Although breast fibroadenomas are noncancerous, they can cause pain and affect the look, shape and feel of breasts. They usually do not affect breast cancer risk.

Conventional fibroadenoma treatment includes close monitoring for changes or growth, or surgical excision to remove breast fibroadenomas. However, a novel, FDA approved treatment called cryoablation offers many women an alternative option.